Seth Lederman

Dr. Seth Lederman, MD, is a President & Director at Tonix Pharmaceuticals (Canada), Inc., a Chairman & Chief Executive Officer at Starling Pharmaceuticals, Inc., a Chairman at Krele LLC, a Chairman, President & Chief Executive Officer at Tonix Pharmaceuticals Holding Corp., a Chairman & President at Tonix Pharmaceuticals, Inc. and a Managing Member at Lederman Seth Co. LLC.
He is on the Board of Directors at Tonix Pharmaceuticals (Canada), Inc. Dr. Lederman was previously employed as a Member by The U.S.-Japan Business Council, Inc., a Chairman & Chief Executive Officer by Leder Laboratories, Inc., a Chairman, President & Chief Executive Officer by Tamandare Explorations, Inc., a Chairman by Fontus Pharmaceuticals, Inc., a Managing Partner by Konanda General Partner LLC, a Managing Partner by Konanda Pharma Partners LLC, a Chairman by Validus Pharmaceuticals LLC, a Founder by Ivrea Pharmaceuticals, Inc., a Managing Member by Lederman & Co. LLC, a Managing Member by Plumbline LLC, a Managing Member by Targent Pharmaceuticals LLC, a Manager by L&L Technologies, Inc., an Associate Professor by Columbia University, a Laboratory Director by Columbia University College of Physicians & Surgeons, a Chairman by Validus LLC, and a Chairman by Vela Pharmaceuticals, Inc. He also served on the board at Tonix Pharma Holdings Ltd., Tonix Pharma Ltd., Tonix Pharmaceuticals (Barbados) Ltd., Konanda Pharma Fund I LP and The Research Corp.
of Long Island, Inc. He received his undergraduate degree from Princeton University and a doctorate degree from Columbia University College of Physicians & Surgeons.